Systematic review and meta-analysis of the influence of HER2 expression and amplification in operable oesophageal cancer. (Q38030442)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22843084%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

meta-analysis

0 references

title

Systematic review and meta-analysis of the influence of HER2 expression and amplification in operable oesophageal cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22843084%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

1 reference

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22843084%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Wyn Lewis

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22843084%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

author name string

David S Y Chan

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22843084%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

language of work or name

1 reference

28 July 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22843084%20AND%20SRC:MED&resulttype=core&format=json

Journal of Gastrointestinal Surgery

9 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22843084%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

volume

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22843084%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22843084%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

page(s)

1821-1829

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22843084%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s11605-012-1979-2

9 February 2020

exact match

0 references

cites work

Global cancer statistics, 2002

1 reference

https://api.crossref.org/works/10.1007%2FS11605-012-1979-2

Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-012-1979-2

The ErbB receptors and their ligands in cancer: an overview.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-012-1979-2

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-012-1979-2

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-012-1979-2

Bias in location and selection of studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-012-1979-2

Direct genetic analysis of single disseminated cancer cells for prediction of outcome and therapy selection in esophageal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-012-1979-2

HER-2/neu gene amplification by FISH predicts poor survival in Barrett's esophagus-associated adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-012-1979-2

HER2 amplification, overexpression and score criteria in esophageal adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-012-1979-2

Assessment of ErbB2 (Her2) in oesophageal adenocarcinomas: summary of a revised immunohistochemical evaluation system, bright field double in situ hybridisation and fluorescence in situ hybridisation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-012-1979-2

Prognostic value of DNA ploidy and c-erbB-2 oncoprotein overexpression in adenocarcinoma of Barrett's esophagus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-012-1979-2

Prognostic value of Laurén classification and c-erbB-2 oncogene overexpression in adenocarcinoma of the esophagus and gastroesophageal junction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-012-1979-2

Her-2/neu gene amplification in esophageal adenocarcinoma and its influence on survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-012-1979-2

Evaluation of gene amplification and protein expression of HER-2/neu in esophageal squamous cell carcinoma using Fluorescence in situ Hybridization (FISH) and immunohistochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-012-1979-2

Frequencies of HER-2/neu expression and gene amplification in patients with oesophageal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-012-1979-2

Expression of c-erbB-2 oncogene product in Barrett's adenocarcinoma: pathological and prognostic correlations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-012-1979-2

Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-012-1979-2

Assessment of a HER2 scoring system for gastric cancer: results from a validation study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-012-1979-2

c-erbB-2 oncoprotein expression related to chemoradioresistance in esophageal squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-012-1979-2

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-012-1979-2

HER-2 overexpression (3+) in patients with squamous cell esophageal carcinoma correlates with poorer survival

21 January 2018

1 reference

12 December 2020

Esophageal cancer chemotherapy: recent advances.

1 reference

12 December 2020

Concomitant analysis of the epidermal growth factor receptor family in esophageal cancer: overexpression of epidermal growth factor receptor mRNA but not of c-erbB-2 and c-erbB-3

1 reference

12 December 2020

Anti-HER2-antibody enhances irradiation-induced growth inhibition in head and neck carcinoma

1 reference

12 December 2020

Immunohistochemical detection of p53 and c-erbB-2 in oesophageal carcinoma; no correlation with prognosis

1 reference

12 December 2020

Frequent homogeneous HER-2 amplification in primary and metastatic adenocarcinoma of the esophagus

1 reference

12 December 2020

The significance of c-erb B-2 and p53 immunoreactivity in patients with adenocarcinoma of the esophagus

1 reference

12 December 2020